Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added, announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.5%
    Check dated 2026-10-25T01:58:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:45:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:08:46.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    In the record history, the label for finding contact information is capitalized differently ('Find contact information' vs 'Find Contact Information'), and the revision tag updates from v3.6.6 to v3.7.0.
    Difference
    0.1%
    Check dated 2026-09-20T01:03:56.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry v3.6.6, replacing the previous v3.6.5 entry. This updates the study's revision history to reflect a latest change to the record.
    Difference
    0.1%
    Check dated 2026-08-29T20:19:38.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new version entry (32) was added to the Record History, introducing Contacts/Locations and Study Status sections for the study record. This updates how changes to the record are tracked and displayed.
    Difference
    0.4%
    Check dated 2026-08-22T22:20:27.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.